GUILLERMO
LÓPEZ VIVANCO
Ikertzailea 2022-(e)ra arte
KU Leuven
Lovaina, BélgicaKU Leuven-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2022
2012
-
Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: A randomized phase II trial
Annals of Oncology, Vol. 23, Núm. 7, pp. 1780-1788
-
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: A randomised phase II study
British Journal of Cancer, Vol. 107, Núm. 3, pp. 435-441